MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

When taking those first steps on your road to running for weight loss, it’s not always as easy as heading out the door. Just ...

Break free of weight cycling: With rounds of dieting can come the fluctuations of the number on the scale, and crash diets ...

Rapid Weight Loss Centers' 20-Year Approach to Real Food and Sustainable Results Shares Core Principles with Federal ...

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility ...

CMS has launched the BALANCE Model, a five-year test to lower costs & expand Medicare access to GLP-1 weight-loss drugs while ...

SAN FRANCISCO, Jan 12 (Reuters) - Eli Lilly's research and development head said on Monday the company will have plenty of ...

Dr. Ian Smith shares why the last 10–15 pounds are so hard to lose and explains how to break through weight-loss plateaus ...

Psychological research increasingly suggests that the start of a new year allows individuals to separate past failures from ...

Research has shown that people who stop taking GLP-1 drugs, such as Ozempic and Wegovy, typically experience weight regain within 2 years.

Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to ...

Stopping weight loss medication led to weight regain and reversed improvements in cardiometabolic markers in under 2 years, ...